RESUMO
Throughout this study, we present the victorious synthesis of a novel class of 2(1H)-pyridone molecules, bearing a 4-hydroxyphenyl moiety through a one-pot reaction of 2-cyano-N-(4-hydroxyphenyl)acetamide with cyanoacetamide, acetylacetone or ethyl acetoacetate, and their corresponding aldehydes. In addition, the chromene moiety was introduced into the pyridine skeleton through the cyclization of the cyanoacetamide 2 with salicylaldehyde, followed by treatment with malononitrile, ethyl cyanoacetate, and cyanoacetamide, in order to improve their biological behaviour. Due to their anti-inflammatory, ulcerogenic, and antipyretic characters, the target molecules have undergone in-vitro and in-vivo examination, that display promising results. Moreover, in order to predict the physicochemical and ADME traits of all synthesized compounds and standard reference drugs, paracetamol and phenylbutazone, the in-silico prediction methodology was provided.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Antiulcerosos/farmacologia , Antipiréticos/farmacologia , Edema/tratamento farmacológico , Febre/tratamento farmacológico , Piridonas/farmacologia , Úlcera Gástrica/tratamento farmacológico , Animais , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Antiulcerosos/síntese química , Antiulcerosos/química , Antipiréticos/síntese química , Antipiréticos/química , Relação Dose-Resposta a Droga , Edema/metabolismo , Interleucina-6/antagonistas & inibidores , Interleucina-6/metabolismo , Masculino , Estrutura Molecular , Piridonas/síntese química , Piridonas/química , Ratos , Saccharomyces cerevisiae/efeitos dos fármacos , Úlcera Gástrica/patologia , Relação Estrutura-AtividadeRESUMO
Although acetaminophen (ApAP) is one of the most commonly used medicines worldwide, hepatotoxicity is a risk with overdose or in patients with compromised liver function. ApAP overdose is the most common cause of acute fulminant hepatic failure. Oxidation of ApAP to N-acetyl-p-benzoquinone imine (NAPQI) is the mechanism for hepatotoxicity. 1 is a non-hepatotoxic, metabolically unstable lipophilic ApAP analog that is not antipyretic. The newly synthesized 3 is a non-hepatotoxic ApAP analog that is stable, lipophilic, and retains analgesia and antipyresis. Intraperitoneal or po administration of the new chemical entities (NCEs), 3b and 3r, in concentrations equal to a toxic dose of ApAP did not result in the formation of NAPQI. Unlike livers from NCE-treated mice, the livers from ApAP-treated mice demonstrated large amounts of nitrotyrosine, a marker of mitochondrial free radical formation, and loss of hepatic tight junction integrity. Given the widespread use of ApAP, hepatotoxicity risk with overuse, and the ongoing opioid epidemic, these NCEs represent a novel, non-narcotic therapeutic pipeline.
Assuntos
Acetamidas/farmacologia , Analgésicos/farmacologia , Antipiréticos/farmacologia , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Hipertermia/tratamento farmacológico , Fígado/efeitos dos fármacos , Acetamidas/síntese química , Acetamidas/química , Ácido Acético , Analgésicos/síntese química , Analgésicos/química , Animais , Antipiréticos/síntese química , Antipiréticos/química , Doença Hepática Induzida por Substâncias e Drogas/patologia , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/tratamento farmacológico , Fígado/patologia , Masculino , Camundongos , Estrutura Molecular , Ratos , Relação Estrutura-AtividadeRESUMO
Paeonol, 2-hydroxy-4-methoxy acetophenone, is one of the main active ingredients of traditional Chinese medicine such as Cynanchum paniculatum, Paeonia suffruticosa Andr and Paeonia lactiflora Pall. Modern medical research has shown that paeonol has a wide range of pharmacological activities. In recent years, a large number of studies have been carried out on the structure modification of paeonol and the mechanism of action of paeonol derivatives has been studied. Some paeonol derivatives exhibit good pharmacological activities in terms of antibacterial, anti-inflammatory, antipyretic analgesic, antioxidant and other pharmacological effects. Herein, the research progress on paeonol derivatives and their pharmacological activities were systematically reviewed.
Assuntos
Acetofenonas/química , Acetofenonas/farmacologia , Antibacterianos/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Antioxidantes/farmacologia , Antipiréticos/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Acetofenonas/síntese química , Animais , Antibacterianos/síntese química , Antibacterianos/química , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Antioxidantes/síntese química , Antioxidantes/química , Antipiréticos/síntese química , Antipiréticos/química , Medicamentos de Ervas Chinesas/síntese química , Medicamentos de Ervas Chinesas/química , Humanos , Medicina Tradicional Chinesa , Estrutura MolecularRESUMO
Aspirin is currently the most widely used drug worldwide, and has been clearly one of the most important pharmacological achievements of the twentieth century. Historians of medicine have traced its birth in 1897, but the fascinating history of aspirin actually dates back >3500â¯years, when willow bark was used as a painkiller and antipyretic by Sumerians and Egyptians, and then by great physicians from ancient Greece and Rome. The modern history of aspirin precursors, salicylates, began in 1763 with Reverend Stone - who first described their antipyretic effects - and continued in the 19th century with many researchers involved in their extraction and chemical synthesis. Bayer chemist Felix Hoffmann synthesized aspirin in 1897, and 70â¯years later the pharmacologist John Vane elucidated its mechanism of action in inhibiting prostaglandin production. Originally used as an antipyretic and anti-inflammatory drug, aspirin then became, for its antiplatelet properties, a milestone in preventing cardiovascular and cerebrovascular diseases. The aspirin story continues today with the growing evidence of its chemopreventive effect against colorectal and other types of cancer, now awaiting the results of ongoing primary prevention trials in this setting. This concise review revisits the history of aspirin with a focus on its most remote origins.
Assuntos
Anti-Inflamatórios não Esteroides/história , Antipiréticos/história , Aspirina/história , Fármacos Cardiovasculares/história , Inibidores da Agregação Plaquetária/história , Salix , Animais , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/isolamento & purificação , Anti-Inflamatórios não Esteroides/uso terapêutico , Antipiréticos/síntese química , Antipiréticos/isolamento & purificação , Antipiréticos/uso terapêutico , Aspirina/síntese química , Aspirina/isolamento & purificação , Aspirina/uso terapêutico , Fármacos Cardiovasculares/síntese química , Fármacos Cardiovasculares/isolamento & purificação , Fármacos Cardiovasculares/uso terapêutico , História do Século XVIII , História do Século XIX , História do Século XX , História do Século XXI , História Antiga , Humanos , Casca de Planta , Folhas de Planta , Inibidores da Agregação Plaquetária/síntese química , Inibidores da Agregação Plaquetária/isolamento & purificação , Inibidores da Agregação Plaquetária/uso terapêutico , Salix/químicaRESUMO
BACKGROUND: Formally belonging to the non-steroidal anti-inflammatory drug class pyrazolones have long been used in medical practices. OBJECTIVE: Our goal is to synthesize N-methylated 1-aryl-3-polyfluoroalkylpyrazolones as fluorinated analogs of antipyrine, their isomeric O-methylated derivatives resembling celecoxib structure and evaluate biological activities of obtained compounds. METHODS: In vitro (permeability) and in vivo (anti-inflammatory and analgesic activities, acute toxicity, hyperalgesia, antipyretic activity, "open field" test) experiments. To suggest the mechanism of biological activity, molecular docking of the synthesized compounds was carried out into the tyrosine site of COX-1/2. RESULTS: We developed the convenient methods for regioselective methylation of 1-aryl-3- polyfluoroalkylpyrazol-5-ols leading to the synthesis N-methylpyrazolones and O-methylpyrazoles as antipyrine and celecoxib analogs respectively. For the first time, the biological properties of new derivatives were investigated in vitro and in vivo. CONCLUSION: The trifluoromethyl antipyrine represents a valuable starting point in design of the lead series for discovery new antipyretic analgesics with anti-inflammatory properties.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Antipirina/análogos & derivados , Antipirina/farmacologia , Fluorocarbonos/farmacologia , Animais , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/toxicidade , Antipiréticos/síntese química , Antipiréticos/química , Antipiréticos/farmacologia , Antipiréticos/toxicidade , Antipirina/síntese química , Antipirina/toxicidade , Domínio Catalítico , Ciclo-Oxigenase 1/química , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/química , Ciclo-Oxigenase 2/metabolismo , Feminino , Fluorocarbonos/síntese química , Fluorocarbonos/química , Fluorocarbonos/toxicidade , Masculino , Proteínas de Membrana/química , Proteínas de Membrana/metabolismo , Simulação de Acoplamento Molecular , Ratos Sprague-DawleyRESUMO
A series of nitrate ester analogues of the acetaminophen derivative SCP-1 were prepared by triflic acid catalyzed O-acylation of SCP-1 with chloroalkanoyl chlorides followed by nitration with silver nitrate. The chloroesters and corresponding nitrate esters were obtained in high yields. Preliminary hepatotoxicity studies revealed nitrate esters 5b (MD-38) and 5c (MD-39) to be well tolerated by human hepatocytes and had little effect on the three cytochrome P450 enzymes tested (CYP3A4, CYP2E1 and CYP2D6). In addition, the nitrate ester 5c (MD-39) exhibited antipyretic activity similar to acetaminophen.
Assuntos
Acetaminofen/análogos & derivados , Antipiréticos/química , Antipiréticos/uso terapêutico , Febre/tratamento farmacológico , Sacarina/análogos & derivados , Acetaminofen/síntese química , Acetaminofen/química , Acetaminofen/uso terapêutico , Acetaminofen/toxicidade , Animais , Antipiréticos/síntese química , Antipiréticos/toxicidade , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Cristalografia por Raios X , Citocromo P-450 CYP2D6/metabolismo , Citocromo P-450 CYP2E1/metabolismo , Citocromo P-450 CYP3A/metabolismo , Esterificação , Febre/metabolismo , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Humanos , Modelos Moleculares , Nitratos/síntese química , Nitratos/química , Nitratos/uso terapêutico , Nitratos/toxicidade , Ratos , Sacarina/síntese química , Sacarina/química , Sacarina/uso terapêutico , Sacarina/toxicidadeRESUMO
Ibuprofen (IBU) is an effective analgesic, non-steroidal anti-inflammatory drug. Unfortunately, oral IBU can cause adverse gastrointestinal drug reactions, such as bleeding and ulcerations, and increases the risk for stomach or intestinal perforations. In this study, IBU nanoparticles (IBU-NPs) were prepared through emulsion solvent evaporation and freeze-drying to improve their solubility. IBU nanoemulsion and nanosuspension were optimized through a single-factor experiment. IBU-NPs with a mean particle size of 216.9±10.7nm were produced under optimum conditions. These IBU-NPs were characterized by using scanning electron microscopy, X-ray diffraction, differential scanning calorimetry, and residual solvent determination to determine their solvent residue, equilibrium solubility, dissolution rate, in vitro transdermal rate, transdermal bioavailability, and antifebrile experiment for febrile rats. The morphological characteristic of IBU-NPs showed porous clusters. Analysis results indicated that the prepared IBU-NPs have low crystallinity. Residual amounts of ethanol and chloroform were 170 and 9.6ppm, respectively, which were less than the ICH limit for class II. Measurement analysis showed that the IBU-NPs were converted underwent amorphous states after preparation, but the chemical structure of the IBU-NPs was unchanged. Transdermal bioavailability of IBU in the IBU-NP group improved significantly compared with oral and transdermal raw IBU. Furthermore, the IBU-NP transdermal gel exhibited a high and stable cooling rate and a long cooling duration in febrile rats. In comparison with the raw oral IBU and raw IBU transdermal gel, the IBU-NP transdermal gel manifested better efficacy at low and mid doses. Basing from the results, we conclude that IBU-NPs can be applied in transdermal delivery formulations and have potential application value for non-oral administration.
Assuntos
Antipiréticos/metabolismo , Química Farmacêutica/métodos , Ibuprofeno/metabolismo , Nanopartículas/metabolismo , Absorção Cutânea/efeitos dos fármacos , Solventes/metabolismo , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/metabolismo , Antipiréticos/administração & dosagem , Antipiréticos/síntese química , Relação Dose-Resposta a Droga , Emulsões , Ibuprofeno/administração & dosagem , Ibuprofeno/síntese química , Nanopartículas/administração & dosagem , Nanopartículas/química , Ratos , Ratos Sprague-Dawley , Absorção Cutânea/fisiologia , Solventes/administração & dosagem , Solventes/síntese químicaRESUMO
As a part of ongoing studies in developing new potent anti-inflammatory and analgesic agents, a series of novel 6-methoxy naphthalene derivatives was efficiently synthesized and characterized by spectral and elemental analyses. The newly synthesized compounds were evaluated for their anti-inflammatory activities using carrageenin-induced rat paw edema model, analgesic activities using acetic acid induced writhing model in mice and anti-pyretic activity using yeast induced hyperpyrexia method as well as ulcerogenic effects. Among the synthesized compounds, thiourea derivative (6a, e) exhibited higher anti-inflammatory activity than the standard drug naproxen in reduction of the rat paw edema (88.71, 89.77%) respectively. All of the non-carboxylic tested compounds were found to have promising anti-inflammatory, analgesic and antipyretic activity, while were devoid of any ulcerogenic effects.
Assuntos
Analgésicos/farmacologia , Anti-Inflamatórios/farmacologia , Antipiréticos/farmacologia , Propionatos/farmacologia , Analgésicos/síntese química , Analgésicos/química , Animais , Anti-Inflamatórios/síntese química , Anti-Inflamatórios/química , Antipiréticos/síntese química , Antipiréticos/química , Carragenina , Modelos Animais de Doenças , Edema/tratamento farmacológico , Edema/patologia , Febre/tratamento farmacológico , Febre/patologia , Inflamação/tratamento farmacológico , Inflamação/patologia , Masculino , Camundongos , Naftalenos/síntese química , Naftalenos/química , Naftalenos/farmacologia , Naproxeno/farmacologia , Dor/tratamento farmacológico , Dor/patologia , Propionatos/síntese química , Propionatos/química , Ratos , Ratos Wistar , Úlcera/induzido quimicamenteRESUMO
A series of substituted pyridinylpyrazole (or isoxazole) derivatives were synthesized and evaluated for their anti-inflammatory (AI) activity using formalin-induced paw edema bioassays. Their inhibitory activities of cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) were also determined. The analgesic activity of the same compounds was evaluated using rat-tail withdrawal technique. Their antipyretic activity was also evaluated. The results revealed that compounds 4a,b, 6a, 8a, 14c and 15a exhibited significant AI and analgesic activities. Compounds 5a, 6a and 8a displayed good antipyretic activity. Compounds 14c and 15a showed good COX-2 inhibitory activity and weak inhibition of COX-1. Additionally, the most active compounds were shown to have a large safety margin (ALD50 >300-400 mg / Kg) and minimal ulcerogenic potentialities when administered orally at a dose of 300 mg/Kg. Docking studies for 14c and 15a with COX-2 showed good binding profile. Antimicrobial evaluation proved that most of the compounds exhibited distinctive activity against the gram negative bacteria, P. aeruginosa and E coli.
Assuntos
Analgésicos/farmacologia , Antibacterianos/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Antipiréticos/farmacologia , Desenho de Fármacos , Isoxazóis/farmacologia , Pirazóis/farmacologia , Piridinas/farmacologia , Analgésicos/administração & dosagem , Analgésicos/síntese química , Animais , Antibacterianos/administração & dosagem , Antibacterianos/síntese química , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/síntese química , Antipiréticos/administração & dosagem , Antipiréticos/síntese química , Ciclo-Oxigenase 2/metabolismo , Relação Dose-Resposta a Droga , Edema/induzido quimicamente , Edema/tratamento farmacológico , Escherichia coli/efeitos dos fármacos , Formaldeído , Isoxazóis/síntese química , Isoxazóis/química , Masculino , Testes de Sensibilidade Microbiana , Modelos Moleculares , Estrutura Molecular , Pseudomonas aeruginosa/efeitos dos fármacos , Pirazóis/síntese química , Pirazóis/química , Piridinas/síntese química , Piridinas/química , Ratos , Ratos Wistar , Relação Estrutura-AtividadeRESUMO
In the last decade, organocatalysis, the use of small chiral organic molecules as catalysts, has proven to be a valuable and attractive tool for the synthesis of enantiomerically enriched molecules. A number of organocatalysts and processes, such as one-pot, tandem, cascade or multicomponent reactions, have been reported to date. Furthermore, the many advantages of organocatalysis - robust, non-toxic, affordable, inert atmosphere, easy reaction manipulation, etc. - allow the preparation of bioactive compounds using simple and metal-free procedures, thus avoiding false positives in the biological evaluation. This mini-review focuses on medicinal chemistry programs that have synthesized biologically active compounds using one or more organocatalytic steps. In this respect, the potential of organocatalytic methods for enabling the chemical synthesis of important medicinal targets will be highlighted.
Assuntos
Química Farmacêutica/métodos , Preparações Farmacêuticas/síntese química , Antineoplásicos/síntese química , Antineoplásicos/química , Antiparasitários/síntese química , Antiparasitários/química , Antipiréticos/síntese química , Antipiréticos/química , Antivirais/síntese química , Antivirais/química , Catálise , Fármacos Neuroprotetores/síntese química , Fármacos Neuroprotetores/química , Compostos Orgânicos/química , Preparações Farmacêuticas/químicaRESUMO
Cyclooxygenase (COX) has been considered as a significant pharmacological target because of its pivotal roles in the prostaglandin biosynthesis and following cascades that lead to various (patho)physiological effects. Non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatment of fever, inflammation, and pain; however, nonselective COX inhibitors exhibit serious side-effects such as gastrointestinal damage because of their inhibitory activities against COX-1. Thus, COX-1 is constitutive and expressed ubiquitously and serves a housekeeping role, while COX-2 is inducible or upregulated by inflammatory/injury stimuli such as interleukin-1ß, tumor necrosis factor-α, and lipopolysaccharide in macrophage, monocyte, synovial, liver, and lung, and is associated with prostaglandin E2 and prostacyclin production that evokes or sustains systemic/peripheral inflammatory symptoms. Also, hypersensitivity of aspirin is a significant concern clinically. Hence, design, synthesis, and structure-activity relationship of [2-{[(4-substituted)-pyridin-2-yl]carbonyl}-(6- or 5-substituted)-1H-indol-3-yl]acetic acid analogues were investigated to discover novel acid-type COX-2 inhibitor as an orally potent new-class anti-pyretic and anti-inflammatory drug. As significant findings, compounds 1-3 demonstrated potent COX-2 inhibitory activities with high selectivities for COX-2 over COX-1 in human cells or whole-blood in vitro, and demonstrated orally potent anti-pyretic activity against lipopolysaccharide-induced systemic-inflammatory fever model in F344 rats. Also compound 1 demonstrated orally potent anti-inflammatory activity against edema formation and a suppressive effect against PGE2 production in carrageenan-induced peripheral-inflammation model on the paw of SD rats. These results suggest that compounds 1-3 are potential agents for the treatment of inflammatory disease and are useful for further pharmacological COX-2 inhibitor investigations.
Assuntos
Acetatos/síntese química , Anti-Inflamatórios não Esteroides/síntese química , Antipiréticos/síntese química , Inibidores de Ciclo-Oxigenase 2/síntese química , Indóis/síntese química , Piridinas/síntese química , Acetatos/química , Acetatos/farmacologia , Administração Oral , Animais , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/farmacologia , Antipiréticos/química , Antipiréticos/farmacologia , Plaquetas/efeitos dos fármacos , Plaquetas/enzimologia , Carragenina , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/metabolismo , Inibidores de Ciclo-Oxigenase 2/química , Inibidores de Ciclo-Oxigenase 2/farmacologia , Dinoprostona/biossíntese , Edema/tratamento farmacológico , Edema/metabolismo , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/enzimologia , Febre/tratamento farmacológico , Febre/etiologia , Humanos , Técnicas In Vitro , Indóis/química , Indóis/farmacologia , Lipopolissacarídeos/farmacologia , Masculino , Piridinas/química , Piridinas/farmacologia , Ratos , Ratos Endogâmicos F344 , Ratos Sprague-Dawley , Relação Estrutura-Atividade , Veias Umbilicais/citologiaRESUMO
Studies in the field of forensic pharmacology and toxicology would not be complete without some knowledge of the history of drug discovery, the various personalities involved, and the events leading to the development and introduction of new therapeutic agents. The first medicinal drugs came from natural sources and existed in the form of herbs, plants, roots, vines and fungi. Until the mid-nineteenth century nature's pharmaceuticals were all that were available to relieve man's pain and suffering. The first synthetic drug, chloral hydrate, was discovered in 1869 and introduced as a sedative-hypnotic; it is still available today in some countries. The first pharmaceutical companies were spin-offs from the textiles and synthetic dye industry and owe much to the rich source of organic chemicals derived from the distillation of coal (coal-tar). The first analgesics and antipyretics, exemplified by phenacetin and acetanilide, were simple chemical derivatives of aniline and p-nitrophenol, both of which were byproducts from coal-tar. An extract from the bark of the white willow tree had been used for centuries to treat various fevers and inflammation. The active principle in white willow, salicin or salicylic acid, had a bitter taste and irritated the gastric mucosa, but a simple chemical modification was much more palatable. This was acetylsalicylic acid, better known as Aspirin®, the first blockbuster drug. At the start of the twentieth century, the first of the barbiturate family of drugs entered the pharmacopoeia and the rest, as they say, is history.
Assuntos
Química Farmacêutica/história , Descoberta de Drogas/história , Alcaloides/análise , Alcaloides/história , Alcaloides/isolamento & purificação , Analgésicos/síntese química , Analgésicos/história , Analgésicos/uso terapêutico , Antipiréticos/síntese química , Antipiréticos/história , Antipiréticos/uso terapêutico , Aspirina/síntese química , Aspirina/história , Aspirina/uso terapêutico , Barbitúricos/síntese química , Barbitúricos/história , Barbitúricos/uso terapêutico , Química Orgânica/história , Hidrato de Cloral/síntese química , Hidrato de Cloral/história , Hidrato de Cloral/uso terapêutico , Clorofórmio/síntese química , Clorofórmio/história , Clorofórmio/uso terapêutico , Indústria Farmacêutica/história , História do Século XVIII , História do Século XIX , História do Século XX , História Antiga , Humanos , Preparações Farmacêuticas/síntese química , Preparações Farmacêuticas/história , Farmacologia/história , Preparações de Plantas/química , Preparações de Plantas/história , Preparações de Plantas/isolamento & purificação , Preparações de Plantas/uso terapêutico , Toxicologia/históriaRESUMO
To develop novel nonallergenic pyrazolone analgesics, we synthesized a series of compounds in which position 1 of the pyrazolone ring was substituted in place of the original methyl group in order to block the formation of allergenic metabolites via N-dealkylation. These pyrazolone analogues were found to show as potent an antipyretic and analgesic effect as antipyrine (AT). In an examination of allergenicity, AT induced a typical skin reaction in guinea pigs, whereas the pyrazolone analogues were inactive. When AT was administered (po) to rats, norantipyrine (NORA) as an active metabolite was detected in the urine, whereas similar administration of the pyrazolone analogues did not afford NORA. We conclude that these novel pyrazolone analogues were nonallergenic because they were not converted to allergenic metabolites in vivo. Because these compounds retain the antipyretic and analgesic activities of AT, they are considered to be promising candidates for nonallergenic antipyretic analgesics.